Joanna Phillips
Neuropathology San Francisco, CA Medical Doctor
NPI 1205002235 CMS profile 454461
505 Parnassus Ave, M551, Box #0102, San Francisco, CA 94143
General payments
$0
Research payments
$415
Ownership & investment interest
$0
Through program year 2024, Joanna Phillips of San Francisco, CA is reported in the CMS Open Payments database as having received $0 across 0 general payments and $415 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | Research | $415 | 2 |
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neuropathology in California
Related records
Neuropathology in California
Practitioners in the same specialty and state, ranked by reported value.
All Neuropathology
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.